Concord Drugs Ltd | Scrip Code : 538965 | Quarter ending :June 2018 |
| Declaration
| |
|
|
Whether the Listed Entity has issued any partly paid up shares? | No | Whether the Listed Entity has issued any Convertible Securities ? | No | Whether the Listed Entity has issued any Warrants ? | Yes | Whether the Listed Entity has any shares against which depository receipts are issued? | No | Whether the Listed Entity has any shares in locked-in? | Yes | Whether any shares held by promoters are pledge or otherwise encumbered? | No | Whether company has equity shares with differential voting rights? | No |
| Summary statement holding of specified securities
| |
|
|
(A) Promoter & Promoter Group | 4 | 30,58,500 | 30,58,500 | 38.90 | 30,58,500 | 38.90 | 6,82,000 | 43.78 | 22,56,600 | 73.78 | 30,58,500 | - | - | - | (B) Public | 1,859 | 48,03,250 | 48,03,250 | 61.10 | 48,03,250 | 61.10 | | 56.22 | | 0.00 | 40,27,350 | - | - | - | (C1) Shares underlying DRs | | | | 0.00 | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C2) Shares held by Employee Trust | | | | 0.00 | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C) Non Promoter-Non Public | | | | 0.00 | | 0.00 | | 0.00 | | 0.00 | | - | - | - | Grand Total | 1,863 | 78,61,750 | 78,61,750 | 100.00 | 78,61,750 | 100.00 | 6,82,000 | 100.00 | 22,56,600 | 28.70 | 70,85,850 | - | - | - |
| Note:C=C1+C2 Grand Total=A+B+C
|